DESIGN AND CHARACTERIZATION OF FLOATING MICROPARTICLES OF A CYCLOOXYGENASE INHIBITOR FOR ARTHRITIS RELATED DISORDERS by Akhand, Khushbu
Akhand et al                                           Journal of Drug Delivery & Therapeutics; 2013, 3(6), 6-13    6 
© 2011, JDDT. All Rights Reserved                                              ISSN: 2250-1177                                                 CODEN (USA): JDDTAO 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
DESIGN AND CHARACTERIZATION OF FLOATING MICROPARTICLES OF A 
CYCLOOXYGENASE INHIBITOR FOR ARTHRITIS RELATED DISORDERS 
Khushbu Akhand*, Mithun Bhowmick, Girijesh Kumar Pandey, Amit Joshi, 
  Balkrishna Dubey 
TIT College of Pharmacy, Bhopal, India 













Oral controlled release dosage forms have been developed 
over the past three decades due to their considerable 
therapeutic advantages such as ease of administration, 
patient compliance and flexibility in formulation1. One 
requisite for successful performance of oral controlled 
drug delivery system is that drug should have good 
absorption throughout the gastrointestinal tract, preferably 
by passive diffusion. These considerations have led to the 
development of a unique oral controlled release dosage 
form with Gastroretentive properties. After oral 
administration, such a dosage form (DF) would be retained 
in the stomach and releases the drug there in a controlled 
and prolonged manner, so that the drug could be supplied 
continuously to its absorption sites in the upper 
gastrointestinal tract. Gastroretentive dosage forms 
(GRDFs) can remain in the gastric region for several hours 
and hence significantly prolong the gastric residence time 
of drugs. Prolonged gastric retention improves 
bioavailability, reduces drug waste, and improves 
solubility of drugs that are less soluble in a high pH 
environment. It is also suitable for local drug delivery to 
the stomach and proximal small intestines. 1,3  Floating 
microspheres are gastro-retentive drug delivery systems 
based on non-effervescent approach. Floating 
microspheres are spherical empty particles without core. 
When the microspheres come in contact with gastric fluid, 
the gel forming polysaccharides and polymers hydrate to 
form a colloidal gel barrier that controls the rate of fluid 
penetration into the device and consequent drug release. 
As the exterior surface of the dosage form dissolves, the 
gel layer is maintained by the hydration of the adjacent 
hydrocolloid layer. The air trapped by the swollen polymer 
lowers the density and confers buoyancy to the 
microspheres. However, a minimal gastric content needed 
to allow proper achievement of buoyancy.4-11                               
MATERIALS AND METHODS 
Materials 
Ketoprofen, Hydroxypropyl methylcellulose, Ethyl 
cellulose, Eudragit S-100, Dichloro methane, Methanol. 
Methods 
Preparation of Floating Microspheres of Ketoprofen
1-5
 
Floating microspheres were prepared by the solvent 
evaporation method. Various concentration of polymer in 
dichloromethane were mixed well with 500 mg of the 
Ketoprofen with different proportion of polymer as shown 
in Table were dissolved in dichloromethane (5 ml) and this 
pasty, flowable mass was introduced  into 50ml of aqueous 
saline phase containing 0.04 % (20 mg) polyvinyl alcohol 
(PVA) and 10% (5 ml) methanol. The system is stirred 
using propeller at 300 rpm at room temperature for 2-3 hr. 
The drug loaded floating microspheres formed were 





Floating drug  delivery  system  is  one  of  the  novel  drug  delivery  system. Floating drug delivery system such as 
microspheres have a bulk density less than gastric fluids and thus it remains buoyant in the stomach and thus it remains 
buoyant on stomach content for long time in the drug releasing process. Hence it is useful for obtaining sufficient 
bioavailability for long time and effective plasma level. Microspheres provide a constant & prolonged therapeutic effect which 
will reduce dosing frequency. Ketoprofen is a nonsteroidal anti-inflammatory drug with well established analgesic and 
antiarthritic effect by inhibiting the prostaglandin and leukotriene synthesis. It is widely used for the treatment of arthritis 
related disorders such as rheumatoid arthritis, osteoarthritis, and ankylosing  spondylitis. But it requires frequent 
administration to maintain the plasma drug concentration as the half life of the drug is less and when administered orally. The 
short half-life and the low single administration dose make ketoprofen a very good candidate for the formulation  of  controlled  
release dosage  forms such as microspheres. It was  also reported  that  microspheres  of  nonsteroidal  anti -inflammatory  
drug,  reduce gastrointestinal  tract  irritation.  
Keywords: Floating drug delivery system, microspheres, Ketoprofen, rheumatoid arthritis, osteoarthritis, and ankylosing  
spondylitis 
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Formulation Design  
Table1: Formulation of Ketoprofen Floating Microspheres 
Formulation code Eudragit S-100 Ethyl cellulose Dichloromethane:Methanol 
F1 0.5 - 1:1 
F2 1.0 - 1:1 
F3 1.5 - 1:1 
F4 - 0.5 1:1 
F5 - 1.0 1:1 
F6 - 1.5 1:1 
 




The prepared microspheres of all batches were accurately 
weighed. The measured weight of prepared microspheres 
was divided by the total amount of all the excipients and 
drug used in the preparation of the microspheres, which 
give the total percentage yield of floating microspheres. It 





The prepared microspheres are characterized by their 
micromeritic properties, such as microsphere size, tapped 
density, Carr‟s compressibility index, Hausner‟s ratio and 
angle of repose. 
Bulk Density  
The bulk density is defined as the mass of powder divided 
by bulk volume. The bulk density was calculated by 
dividing the weight of the samples in grams by the final 
volume in cm3 
 
Tapped Density 
Tapped density is the volume of powder determined by 
tapping by using a measuring cylinder containing weighed 
amountof sample. The cylinder containing known amount 
of microspheres was tapped for about 1 minute on a tapped 
density apparatus until it gives constant volume. 
 
Carr’s Compressibility Index 
This is an important property in maintaining uniform 
weight. It is calculated using following equation, 
 
 
Lower the compressibility values indicate better flow.  
Table 2: Relationship between % Compressibility and 
Flowability 
% Compressibility Flowability 
5-15 Excellent 
12 – 16 Good 
18 – 21 Fair to passable 
23 – 35 Poor 
33 – 38 Very poor 
> 40 Extremely poor 
 
Hausner ratio 
A similar index like percentage compressibility index has 
been defined by Hausner. Values less than 1.25 indicate 
good flow, where as greater than 1.25 indicates poor flow. 
Added glidant normally improve flow of the material 
under study. Hausner‟s ratio can be calculated by formula, 
 
Angle of Repose (θ)  
Good flow properties are critical for the development of 
any pharmaceutical tablet, capsules or powder formulation. 
It is essential that an accurate assessment of flow 
properties be made as early in the development process as 
possible so that an optimum formulation can be quickly 
identified. Interparticle forces between particles as well as 
flow characteristics of powders are evaluated by angle of 
repose. Angle of repose is defined as the maximum angle 
possible between the surface and the horizontal plane.  
The angle of repose of each powder blend was determined 
by glass funnel method. Powders were weighed accurately 
and passed freely through the funnel so as to form a heap. 
The height of funnel was soadjusted that the tipof the 
funnel just touched the apex of the heap. The diameter of 
the powder cone so formed was measured and the angle of 
repose was calculated using the following equation, 
 
Where, θ= angle of repose  
h = height of the pile and,  
r = radius of the powder cone respectively.  
Angle of repose affects particle size distribution, as larger 
the particle size, it will flow freely and vice-versa. It is a 
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helpful parameter to monitor quality of powdered or 
granular pharmaceutical formulations. For good flowing 
materials the, angle of repose should be less than 30°. 
Table 3: Relationship between Angle of Repose and 
Flowability 
Angle of Repose Flowability 
< 25 Excellent 
25-30 Good 
30-40 Passable 





Microsphere size was determined by using an optical 
microscope under regular polarized light, and the mean 
microsphere size was calculated by measuring 100 
particles with the help of a calibrated ocular micrometer.  
Morphological Study using SEM
13,18
 
The morphological study was carried out by Scanning 
Electron Microscope (SEM). Microspheres were scanned 
and examined under Electron Microscope HITACHI SU 
1500, Japan connected with Fine coat, JEOL JFC-1100E 
Ion sputter. The sample was loaded on copper sample 
holder and sputter coated with carbon followed by Gold.  
Drug Loading and Drug Entrapment
17,18,19
 
Floating microspheres were dissolved in a minimum 
amount of methanol and drug was extracted into 0.1 N 
hydrochloric acid by evaporating methanol. The solution 
was filtered through whatman filter paper, diluted suitably 
and analyzed for drug content spectrophotometrically at 
254 nm using 0.1N hydrochloric acid as blank. The 
amount of drug loaded and entrapped in the microspheres 
was calculated by the following formulas: 
 
 
In vitro Buoyancy Study
15,16
 
Microspheres (300mg) were spread over the surface of a 
USP dissolution apparatus type II filled with 900 ml of 0.1 
N HCl (pH-1.2) containing 0.02% tween 80. The medium 
was agitated with a paddle rotating at 100 rpm for 12 h. 
The floating and the settled portions of microspheres were 
recovered separately. The microspheres were dried and 
weighed. Buoyancy percentage was calculated as the ratio 
of the mass of the microspheres that remained floating and 
the total mass of the microspheres. 
 
Where Wf and Ws are the weights of the floating and 
settled micropshers, respectively. All the determinations 




The drug release study was performed for microsphere 
containing quantity equivalent to 150 mg of ketoprofen by 
using USP dissolution apparatus Type I in 900 ml of 0.1N 
HCl dissolution media (pH-1.2) at 100 rpm and 370C 
temperature. 10 ml of sample was withdrawn at 
predetermined time interval for 12 hours and same volume 
of fresh medium was replaced to maintained sink 
condition. Withdrawn samples were assayed 
spectrophotometrically at 254 nm. Drug release was also 
performed for pure drug. 
Release Kinetics 
The matrix systems were reported to follow the Peppas 
release rate and the diffusion mechanism for the release of 
the drug. To analyse the mechanism for the release and 
release rate kinetics of the dosage form, the data obtained 
was fitted in to, Zero order, First order, Higuchi matrix, 
Peppas. In this by comparing the r-values obtained, the 
best-fit model was selected.  
RESULT AND DISCUSSION 
PREFORMULATION STUDIES 
Organoleptic Property: Physical appearance of drug was 
examined by various organoleptic properties. 
Table 4: Organoleptic Properties 
Organoleptic Property Observation 
Color White or almost white 
Odor Odorless 
Taste Tasteless 
State Fine to granular powder 
 
Melting Point: Melting point of the Ketoprofen was found 
out to be 96OC by capillary fusion method 
Solubility: Ketoprofen was found to be freely soluble in 
ethanol (95%), in chloroform, and in ether, practically 
insoluble in water. Adjusting pH to a higher value can 
solubilize Ketoprofen, as solubility increase at pH values 
above its pKa. 
Table 5: Solubility 
S.NO. SOLVENT SOLUBILITY 
1 Water - 
2 Phosphate buffer 7.4 ++ 
3 0.1 N HCL + 
4 0.1 N NaOH + 
5 Methanol ++ 
6 Ethanol ++ 
7 Chloroform ++ 
8 Dichloromethane ++ 
9 Acetone ++ 
Practically insoluble (-) slightly soluble (+) soluble (++) 
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Development of Calibration Curve for Ketoprofen ( 
λmax) 
The absorption maximum (λmax) is determined as 254 nm. 
Fourier Transform Infrared Spectroscopy:  
On comparing the IR spectra of the reference spectra given 
in Indian Pharmacopoeia (1996) and IR spectra of the pure 
drug, no major differences were observed in the 
characteristic absorption peak pattern, which shows that 
the drug obtained was pure. 
 
  
Figure 1: Calibration Curve for Ketoprofen ( λmax) 
 
 
Figure 2: FTIR spectra of Ketoprofen 










OH str 3000.50 
CH str 2900.01 
CHdf 1290.23 
C=O str 1650 
Ar-H 710 
 
Interference of Additives/Compatibility Testing  
The results of UV spectroscopic analysis indicated that 
there was no chemical interaction between the drug and the 
additives as the respective formulation (Drug and Polymer 
combination) exhibited absorption nearly similar to those 
of the pure drug sample. 
 
Table 7: Interference of Additives/Compatibility Testing 
Formulation 
Absorbance of solutions Interference 
Yes / No Polymer blend with drug Placebo Pure drug 
Ketoprofen-eudragit s100 0.635 0.003 0.633 No 
Ketoprofen-Ethyl cellulose 0.636 0.001 0.633 No 
 
Evaluation of Microspheres 
Percentage yield 
The percentage practical yield slightly decreased as the polymer ratio increased. The results of all formulations F1to F6 of 
floating microsphere are shown in Table 8. 
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Table 8: Percentage yield 
Formulation Code Theoretical Weight ( gm ) Practical Yield (gm) Percentage Yield (%) 
F1 1.0 0.731 73.1 
F2 1.5 0.983 65.53 
F3 2.5 1.509 60.36 
F4 1.0 0.726 72.6 
F5 1.5 1.901 60.06 
F6 2.5 1.414 56.56 
 
Micromeritic Properties 
The results of all formulations F1 to F6 of Floating 
microsphere are shown in Table…, which were evaluated 
for variable parameters such as bulk density, tapped 
density, % Compressibility index, Hausner‟s ratio and 
angle of repose. 
The % Compressibility index was in the range of 11.44-
17.55 for all the formulations F1 to F6 indicating good 
flow property. The value of Hausner‟s ratio for the all 
formulation F1to F6 was below 1.25 which indicates good 
flow property.  
The values of angle of repose for formulations F1to F5 
was found to be in the range of 25o-30o which indicated the 
good flow potential and the formulation F6 showed below 
25o which indicated excellent flow. 











F1 0.144  0.154  
F2 0.447  0.518  
F3 0.513  0.600  
F4 0.402  0.473  
F5 0.445  0.533  
F6 0.462  0.563  
 






Angle of Repose 
(θ) 
F1 11.44  1.120  25°15'  
F2 13.23  1.144  26°10'  
F3 14.19  1.157  26°40'  
F4 14.61  1.162  27°10'  
F5 16.10  1.183  27°90'  
F6 17.55  1.204  28°40'  
 
Particle Size Analysis 
Average particle size of microspheres as determined by 
optical microscopy by using stage micrometer and ocular 
micrometer are shown in Table. 
With increase in Eudragit S-100 and Ethyl cellulose 
concentration in the microspheres from F1 to F3 and F4 to 
F6, the particle size of microspheres increases respectively. 
This is because the viscosity of the polymer solution 
increases with increasing polymer concentration, which in 
turn decreases the stirring efficiency. The polymer rapidly 
precipitates leading to hardening and avoiding further 
particle size reduction during solvent evaporation. The 
average particle size of Eudragit S-100 was greater due to 
the greater viscosity than Ethyl cellulose. 
Table 11: Particle Size Analysis 







Scanning Electron Microscopy 
Morphology of microspheres was examined by scanning 
electron microscopy. The view of the microspheres 
showed a hollow spherical structure with a smooth surface 
morphology and exhibited a range of sizes within each 
batch 
 
                      Figure 3: SEM of Microspheres 
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Drug Loading and Drug Entrapment 
The values of %drug loading and % entrapment efficiency 
are shown in Table. As the polymer concentration was 
increased the % drug loading decreased and %entrapment 
efficiency was increased due to increase in the viscosity of 
the solution. This can be attributed to the permeation 
characteristics of each polymer used, that could facilitate 
the diffusion of part of entrapped drug to the surrounding 
medium during preparation of floating microspheres. 
In vitro Buoyancy Study 
The microspheres prepared by using higher polymer 
concentrations shows high density. So the microspheres 
having higher polymer concentrations were less buoyant 
than those with lower polymers concentrations. 
Ketoprofen-Eudragit S-100 microspheres showed lesser 
buoyancies when compared to the Ketoprofen -Ethyl 
cellulose microspheres because of the lesser number of 
pores in the former. The formulation F4 showed highest 
buoyancy of 87 % while the formulation F3 showed the 
least buoyancy of 76%. 








F1 37.16 75.52 
F2 26.41 81.38 
F3 17.18 89.89 
F4 38.44 77.78 
F5 27.30 83.88 
F6 17.60 92.20 
 
 
Table 13: In vitro Buoyancy Study 
Formulation 
Code 








F1 300 250 83.33 
F2 300 239 79.66 
F3 300 228 76 
F4 300 261 87 
F5 300 252 84 
F6 300 247 82.3 
 
In vitro drug release studies 
Dissolution studies on all the six formulations of 
Ketoprofen floating microspheres were carried out using a 
USP dissolution apparatus Type I. 0.1N HCl (pH 1.2) was 
used as the dissolution medium. The cumulative drug 
release significantly decreased with increase in polymer 
concentration. The increased density of the polymer matrix 
at higher concentrations results in an increased diffusional 
pathlength. This may decrease the overall drug release 
from the polymer matrix. Furthermore, smaller 
microspheres are formed at a lower polymer concentration 
and have a larger surface area exposed to dissolution 
medium, giving rise to faster drug release. 
 
Figure 4: Zero order release kinetics  
First order release kinetics data 
 
             Figure 5: First order release kinetics 
Higuchi matrix release kinetics data 
 
Figure 6: Higuchi matrix release kinetics 
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Peppas release kinetics data 
 
         Figure 7: Peppas release kinetics 
Release Kinetics 
The curve fitting results of the release rate profiles of the 
designed formulation are shown in the Figures … which 
gave an idea on the release rate and the mechanism of 
release. The values were compared with each other for 
model and drug equation as shown in Table ..based on the 
highest regression values (r), fitting of the release rate data 
to the various models revealed that the all the formulations 
follows first order release kinetics. The Peppas model is 
widely used when the release mechanism is not well 
known or when more than one type of release phenomenon 
could be involved. „n‟ value could be used to characterize 
different release mechanisms. The n values for 
formulations F1 to F6 ranged from 0.605 to 0.741, 
indicating that the release mechanism was non-Fickian or 
anomalous release (0.5 <n <1). Based on the n values, F1 
to F6, drug release from microsphere were controlled by 
polymer relaxation (erosion) as well as diffusion.
 
Table 14: Release Kinetics 
Formulation  
code 
Correlation coefficient of Model fitting (R
2
) ‘n’ values for 
-Peppas 
Best fit 
model Zero order First order Higuchi matrix Peppas kinetics 
F1 0.916 0.991 0.978 0.968 0.685 First order 
F2 0.921 0.986 0.976 0.969 0.713 First order 
F3 0.892 0.971 0.969 0.959 0.605 First order 
F4 0.895 0.989 0.973 0.964 0.653 First order 
F5 0.889 0.983 0.974 0.961 0.712 First order 
F6 0.887 0.984 0.964 0.950 0.741 First order 
           
CONCLUSION 
Floating microspheres have a bulk density less than gastric 
fluids and thus it remains buoyant in the stomach without 
affecting gastric emptying rate for a prolonged period of 
time. While the system is floating on the gastric contents, 
the drug is released slowly at the desired rate from the 
system. Also floating microspheres provide a constant and 
prolonged therapeutic effect which will reduce dosing 
frequency. 
In the present study, floating microspheres of ketoprofen 
were prepared using different polymers like ethyl cellulose 
and eudragit by solvent evaporation diffusion method. 
The surface morphology of the prepared floating 
microspheres was studied using scanning electron 
microscopy. The prepared floating microspheres also 
characterized by FTIR spectroscopy and UV-Spectroscopy 
was used to find out any chemical interaction between 
Ketoprofen and polymers used. The prepared floating 
microspheres were evaluated for particle size,percentage 
yield, drug entrapment efficiency, micromeritic properties 
(like bulk density, tapped density, hausners ratio, angle of 
repose, compressibility index) in vitro buoyancy and in 
vitro drug release study and as described in chapter-4. The 
results indicated that the significant effect was observed of 
increased polymer concentration, on said parameters in 
each case. 
The details of results are given in chapter-5. The mean 
particle size of the microspheres significantly increased 
with increase in polymer concentration. Micromeritic 
study suggested excellentflow properties of prepared 
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